Lets break down what causes them and how to get them under control
In the STEP trials, semaglutide users reported reduced interest in desserts, candy, and sugary beverages compared to placebo groups
Whilst clinical trials have demonstrated substantial improvements in glycaemic control and weight reduction, questions have emerged regarding thyroid safetyspecifically, a theoretical risk of medullary thyroid carcinoma (MTC) identified in rodent studies
Injecting outside approved sites or into areas with poor subcutaneous tissue, active skin conditions, or scar tissue may compromise medication delivery and increase infection risk
Patient assistance programs Eli Lilly offers the Mounjaro Savings Card and the Zepbound Savings Program for eligible patients
The adverse events associated with GLP-1RA are predominantly GI, particularly nausea, vomiting, and diarrhea, and occur in 1050% of patients in clinical trials (Table 2) ( Pancreatitis and Pancreatic Cancer Since the introduction of GLP-1RA and DPP-4 inhibitors there has been some concern regarding the potential increase in pancreatitis and possibly pancreatic cancer with the incretin class of medications